TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study.

S M Swain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.